Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
NCT05525208
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
696
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
BIOLOGICAL:
SARS-CoV-2 subunit protein recombinant vaccine
BIOLOGICAL:
Active Comparator
Sponsor
PT Bio Farma
Collaborators
[object Object]
[object Object]